摘要
从核苷类逆转录酶抑制剂的作用机制、HIV-1对其产生耐药性的分子机制、导致耐药性产生的HIV-1逆转录酶基因突变以及HIV-1产生耐药性的分子水平检测方法等诸方面,概述近年来有关HIV-1对核苷类逆转录酶抑制剂的耐药性在分子水平上的研究进展。核苷类逆转录酶抑制剂是一类重要的抗HIV-1药物,其耐药性病毒株的产生是导致抗HIV-1治疗失败的主要原因。对HIV-1耐药性的分子机制研究必将有助于对耐药性HIV-1有效的新型抗HIV-1药物的研究与开发。
The advances in molecular level study on HIV-1 resistance to nucleoside reverse transcfiptase inhibitors (NRTIs) in recent years, including the mechanism of action of NRTIs, the molecular mechanism of HIV-1 resistance to NRTIs, NRTIs resistant reverse transcriptase mutations and the techniques for detecting HIV-1 resistance mutations, were reviewed. NRTIs are an important class of antiretroviral drugs, to which the emergence of resistant HIV-I mutants is the major cause of failure of antiretreviral therapy. The molecular level study on HIV-1 resistance is sure to promote the research and development of novel anti-HIV-1 drugs that are effective on resistant HIV-1 mutants.
出处
《药学进展》
CAS
2006年第12期535-542,共8页
Progress in Pharmaceutical Sciences